Cover Image
市场调查报告书

生物可吸收支架的全球市场 - 成长,趋势及预测(2017年~2022年)

Global Bioabsorbable Stents Market - Segmented by Type of Product, Application, Absorption Rate, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品编码 391471
出版日期 内容信息 英文 111 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
生物可吸收支架的全球市场 - 成长,趋势及预测(2017年~2022年) Global Bioabsorbable Stents Market - Segmented by Type of Product, Application, Absorption Rate, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年03月01日 内容信息: 英文 111 Pages
简介

据世界卫生组织声称,全球心血管疾病是导致死亡的头号死因,2012年造成约1750万人死亡,占全球死亡人数的31%。其中,估计有740万是因冠心病引起的,670万是因中风引起的。超过75%的死亡来自中等收入国家和低收入国家,因其中出生率较高,因此人口成长率较高。因此,已经患有心血管疾病的庞大人群以及这一人口基数增加的趋势是这个市场的主要推动因素。

本报告提供全球生物可吸收支架市场调查,整体市场趋势,各产品、地区的详细趋势,市场成长的影响要素分析,竞争情形,主要企业简介等,总括性汇整。

目录

第1章 简介

  • 调查成果
  • 市场定义
  • 规模的单位
  • 基本货币
  • 检讨与预测期间
  • 一般的调查的前提条件
  • 关于报告

第2章 调查方法

  • 简介
  • 分析方法论
  • 计量预测模式
  • 调查的前提条件

第3章 摘要整理

第4章 主要影响要素

第5章 市场概要与产业趋势

  • 目前市场方案
  • 波特的五力分析
    • 供应商谈判力
    • 买主谈判力
    • 竞争程度
    • 替代品的威胁
    • 新加入厂商的威胁

第6章 成长要素,阻碍因素,机会及课题分析(DROC)

  • 市场成长要素
    • 心脏血管疾病造成的死亡人数世界第一
    • 老年人的剧增,尤其是已开发国家的增加
    • 生活方式的变化使青年人口容易得到心脏病
    • 心血管疾病的风险高的肥胖人口的扩大基础
    • 消除各代产品出现任何并发症的风险产品所有并发症的风险
  • 市场阻碍因素
    • 严格法规方案
    • 高的设备成本
  • 市场机会
    • 各心血管疾病死亡率最高中、低所得国
    • 生活方式变化的新兴市场
  • 主要课题
    • 确实的成果的替代品
    • 扩张后的反冲等的高的并发症风险

第7章 市场区隔

  • 各产品类型
    • 聚合物为基础的生物可吸收支架
    • 金属为基础的生物可吸收支架
  • 各应用领域
    • 冠状动脉疾病
    • 周边动脉疾病
    • 其他
  • 吸收比
    • 低速吸收比
    • 中间吸收比
    • 高速吸收比
  • 各终端用户
    • 医院
    • 心脏中心
    • 研究所

第8章 各地理市场 - 各地区市场占有率及预测

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙和葡萄牙
    • 义大利
    • 斯堪地那维亚
    • 荷比卢三国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他
  • 中东、非洲地区(MENA)
    • GCC
    • 南非
    • 其他
  • 中南美
    • 阿根廷
    • 巴西
    • 其他

第9章 竞争情形

  • M&A
  • 新产品的销售
  • 协定,合作,联盟

第10章 主要供应商

  • Abbott Laboratories
  • 京都医学规划株式会社
  • Reva Medical
  • Elixir Medical Corporation
  • Amaranth Medical
  • Terumo Corporation
  • Arterius Limited
  • Biotronik
  • Xenogenics Corporation
  • Meril Life Sciences

由于第11章分析师的投资机会的展望

第12章 市场未来展望

第13章 附录

  • 简称
  • 参考文献
  • 免责声明

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 55008

Description

The global bioabsorbable stents market is expected to register a CAGR of 11% during the forecast period (2018 - 2023). Bioabsorbable stents are normally used in the treatment of blocked arteries. These stents are tiny, stretchy mesh tubes that hold arteries open and can help in the treatment of coronary and peripheral artery diseases. Bioabsorbable stents are fully biodegradable stents which will completely disappear over time.

High Prevalence of Cardiovascular Diseases Globally

According to World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally. In 2015, it is estimated that about 17.7 million people died because of cardiovascular diseases and in these deaths, it was estimated that 7.4 million people died because of coronary heart disease and 6.7 million people died of a stroke. Thus, a large number of people are already suffering from these cardiovascular diseases, and with the increase in population the number of people with cardiovascular diseases is expected to rise. This rise in the disease rate is also expected to increase the usage of stents, in turn, it is expected to drive the market during the forecast years. The changing lifestyles, rising obese population, and steep growth in the geriatric population are the major driving factors for the market growth.

High Device Cost

The high cost of the device is a major restraint for the bioabsorbable stents market. The cost of the stent depends on the type, which may cost USD 1800. In addition to the cost of the bioabsorbable stent, other aspects such as the cost of the procedure that can add to the cost of bioabsorbable stent's usage. The high cost of the device hinders the growth of the market, as surgeons prefer the conventional stents over the bioabsorbable stents due to their difference in cost. Along with the high cost, other factors, such as stringent regulatory policies and safety issues related to bioabsorbable stents are also hindering the growth of the market.

Europe to dominate the Market

Europe has the largest market share in bioabsorbable stents market, followed by North America. Asia-Pacific is expected to have the highest growth rate in the forecast period, due to the increasing awareness among people about the procedure and the products. The US FDA has approved only one product, namely Abbott Absorb, and it is now commercially available in the US. However, several products are being developed, some are in clinical trials and others in various stages of development, which is an indication of a bright future for this market.

Key Developments in the Market

September 2017: Abbott Laboratories halted the global sales of their fully absorbable stent-Absorb Bioresorbable Vascular Scaffold (BVS).

April 2017: Reva Medical has secured a CE mark for its drug-eluting bioresorbable coronary scaffold.

Major Players: ABBOTT LABORATORIES, KYOTO MEDICAL PLANNING CO. LTD, REVA MEDICAL, ELIXIR MEDICAL CORPORATION, AMARANTH MEDICAL, TERUMO CORPORATION, ARTERIUS LIMITED, BIOTRONIK, XENOGENICS CORPORATION, AND MERIL LIFE SCIENCES PVT LTD, amongst others.

Reasons to Purchase this Report

Current and future bioabsorbable stents market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threats of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 High Prevalance of Cardiovascular Diseases Globally
    • 6.1.2 Steep Increase in Aging Population, Especially in Developed Countries
    • 6.1.3 Expanding Base of Obese Population
  • 6.2 Market Restraints
    • 6.2.1 Stringent Regulatory Scenario
    • 6.2.2 High Device Cost
    • 6.2.3 Safety Issues Related to Bioabsorbable Stents
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 Segmentation -by Product Type
    • 7.1.1 Polymer Based Bioabsorbable Stents
    • 7.1.2 Metal Based Bioabsorbable Stents
  • 7.2 Segmentation -by Application
    • 7.2.1 Coronary Artery Disease
    • 7.2.2 Peripheral Artery Disease
    • 7.2.3 Others
  • 7.3 Segmentation -by Absorption Rate
    • 7.3.1 Slow Absorption Rate
    • 7.3.2 Intermediate Absorption Rate
    • 7.3.3 Fast Absorption Rate
  • 7.4 Segmentation -by End User
    • 7.4.1 Hospitals
    • 7.4.2 Ambulatory Surgical Centers
    • 7.4.3 Others
  • 7.5 Segmentation - by Geography
    • 7.5.1 North America
      • 7.5.1.1 United States
      • 7.5.1.2 Canada
      • 7.5.1.3 Mexico
    • 7.5.2 Europe
      • 7.5.2.1 France
      • 7.5.2.2 Germany
      • 7.5.2.3 United Kingdom
      • 7.5.2.4 Italy
      • 7.5.2.5 Spain
      • 7.5.2.6 Rest Of Europe
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China
      • 7.5.3.2 Japan
      • 7.5.3.3 India
      • 7.5.3.4 Australia & New Zealand
      • 7.5.3.5 South Korea
      • 7.5.3.6 Rest of Asia-Pacific
    • 7.5.4 Middle East & Africa
      • 7.5.4.1 GCC
      • 7.5.4.2 South Africa
      • 7.5.4.3 Rest of the Middle East & Africa
    • 7.5.5 South America
      • 7.5.5.1 Brazil
      • 7.5.5.2 Argentina
      • 7.5.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers & Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Abbott Laboratories
  • 9.2 Kyoto Medical Planning Co. Ltd
  • 9.3 Reva Medical
  • 9.4 Elixir Medical Corporation
  • 9.5 Amaranth Medical
  • 9.6 Terumo Corporation
  • 9.7 Arterius Limited
  • 9.8 Biotronik
  • 9.9 Xenogenics Corporation
  • 9.10 Meril Life Sciences Pvt. Ltd.
  • 9.11 Others

10. Future of the Market

Back to Top